Having a combined regulatory and market access strategy is critical for a drug launch to be successful.
Marcus Deans, Mark A De Rosch and Emmanuelle Voisin
Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences in 1997. She has 30 years’ experience in drug development. Her expertise lies in non-conventional development strategies, maximizing the use of regulatory mechanisms and innovative approaches to drug development, to bring innovative technologies to patients.
View Profile
